Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Satoshi Kobayashi's publication output changed over time?
ScholarIQpublication output · 1997–2023
Output grew0% over the shown period — from 1 works in 1997 to 1 in 2023.
1
1
1
1
2
1
2
1
1
199720012013201420162017201920222023
What are the most-cited papers on Satoshi Kobayashi?
ScholarIQmost cited works
Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial
Keisuke Uehara, Kazuhiro Hiramatsu, Atsuyuki Maeda, Eiji Sakamoto, M. Inoue, Satoshi Kobayashi, Y. Tojima, Yuichiro Yoshioka, G. Nakayama, Hiroshi Yatsuya, Naoki Ohmiya, Hidemi Goto, Masato Nagino
S149902429. 2013144 CitationsOPEN ACCESS
Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).
Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto, Yoshito Komatsu, Makoto Ueno, Satoshi Kobayashi, Masafumi Ikeda, Mitsuhito Sasaki, Junji Furuse, Naohiro Okano, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka
Journal of Clinical Oncology. 2022108 Citations
Dynamic CT of Hepatic Abscesses
Toshifumi Gabata, Masumi Kadoya, Osamu Matsui, Takeshi Kobayashi, Y Kawamori, Junichiro Sanada, Noboru Terayama, Satoshi Kobayashi
S161085503. 200186 Citations
Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study
T. Kamiya, Keisuke Uehara, Goro Nakayama, Kiyoshi Ishigure, Satoshi Kobayashi, Kazuhiro Hiramatsu, H. Nakayama, Keishi Yamashita, Eiji Sakamoto, Y. Tojima, S. Kawai, Yasuhiro Kodera, Masato Nagino
European Journal of Surgical Oncology. 201655 CitationsOPEN ACCESS
Cholecystectomy in octogenarians: be careful
Yasuyuki Fukami, Yasuhiro Kurumiya, Keisuke Mizuno, Ei SEKOGUCHI, Satoshi Kobayashi
Updates in Surgery. 201449 Citations
Related on ScholarIQ
Kyushu University
Institution
Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial
Paper
Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).
Paper
Dynamic CT of Hepatic Abscesses
Paper
Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study
Paper
Cholecystectomy in octogenarians: be careful
Paper